Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0319 | ||||
| Gene Name | SLC36A2 | ||||
| Protein Name | Proton-coupled amino acid transporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | PAT2; Proton/amino acid transporter 2; SLC36A2; Solute carrier family 36 member 2; TRAMD1; Tramdorin-1 | ||||
| DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
| Tissue Specificity | Abundantly expressed in kidney and muscle.Expressed in the S1 segment of the proximal tubule close to theglomerulus. | ||||
| Function | This transporter involved in a pH-dependent electrogenic neuronal transport and sequestration of small amino acids. Transports glycine and proline. Inhibited by sarcosine. | ||||
| Endogenous Substrate(s) | H+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Cycloserine
|
Approved | Drug Info | Dementia | 6D8Z | [1] |
| References | |||||
| 1 | Substrate specificity and functional characterisation of the H+/amino acid transporter rat PAT2 (Slc36a2). Br J Pharmacol. 2005 Jan;144(1):28-41. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.